Venus Remedies goes further in its fight against AMR by joining the India AMR Innovation Hub.

By joining the India AMR Innovation Hub, Venus Remedies, an upcoming pharmaceutical company in India, has taken a big step in the fight against Antimicrobial Resistance (AMR). Venus is known for its innovative research and development of antibiotics, and this move shows that it is committed to fighting the growing problem of AMR.

The Centre for Cellular and Molecular Platforms (C-CAMP) is in charge of the India AMR Innovation Hub (IAIH), which is a place where people can work together to solve the growing health crisis of antimicrobial resistance (AMR) in India . It aims to make changes to help India build an AMR innovation ecosystem. The IAIH brings national and international stakeholders from government, academia, industry, and not-for-profit organizations to create an AMR innovation ecosystem that includes policy, capacity building, and public communication.

The IAIH works to lessen the threat of AMR by focusing on therapeutics, vaccine development, diagnostics, surveillance, pandemic preparedness, and stewardship.

AMR is a significant threat to global health and could harm individuals and whole communities in evil ways. It happens when bacteria, viruses, fungi, and other microbes become resistant to the medicines used to treat infections. This makes the medication useless. Estimates say that if nothing is done to stop it, AMR could be responsible for up to 10 million deaths annually by 2050.

Joining the India AMR Innovation Hub is a big step in the right direction Venus Remedies has taken. The company has been developing new ways to fight AMR, such as new antibiotics and therapy combinations. By joining the hub, Venus Remedies will have access to more resources and expertise, allowing it to speed up its work and make even more progress in the fight against AMR.

CEO and Director of C-CAMP, Dr Taslimarif Saiyed, welcomed Venus Remedies to the IAIH and emphasized the company's role in boosting efforts to stop AMR.

Saransh Chaudhary, President of Global Critical Care, Venus Remedies, and CEO of Venus Medicine Research Centre (VMRC) said the company's membership in IAIH shows it is still committed to fighting AMR. He said that he thought the work of national and international stakeholders working under the IAIH could be the key to a significant change in the Indian AMR research and innovation landscape.

Venus Remedies is a crucial player in the Indian antibiotics and pharmaceuticals market. It has a history of making sure antibiotics are available and made responsibly, promoting the right way to use antibiotics, doing antibiotic stewardship activities in the clinical domain, and developing new drugs and therapies.

The company is also a part of the AMR Industry Alliance, a worldwide group. Its research and development arm, Venus Medicine Research Centre (VMRC), has set up a non-profit organization, Preserving Life of Existing Antibiotics (PLEA). PLEA wants to become a rallying point in the long-term fight against AMR by putting together scientists, researchers, and clinicians from different fields to work on a national surveillance programme on antibiotic resistance.

Venus Remedies has been working on AMR for more than 20 years. They do this by working on antibiotics and making new drugs. Focusing on research and development has given the company a reputation as a leader in the field. Its choice to join the India AMR Innovation Hub will make it even more determined to develop new ways to fight AMR.

In conclusion, the partnership between Venus Remedies and the India AMR Innovation Hub is a step towards fighting the growing threat of antibiotic resistance in India. National and international stakeholders can work together to develop long-term solutions and make policies that will help close the gaps in antibiotic research and manufacturing, encourage the right way to use antibiotics and take care of them, and ultimately reduce the burden of AMR in the country.

Sources:

• http://www.ccamp.res.in/india-amr-innovation-hub
• https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
• https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis
• https://www.amrindustryalliance.org/
• https://www.vmrcindia.com/
• https://venusremedies.com/plea
• https://www.expresspharma.in/venus-remedies-joins-india-amr-innovation-hub/